Liquid Biopsy, a Potential New Detection Method in Heart Allograft Rejection
Author:
Li Chenghao,Wang Guohua
Reference35 articles.
1. De Vlaminck I, Valantine HA, Snyder TM et al (2014) Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med 6(241):241ra77. https://doi.org/10.1126/scitranslmed.3007803
2. Marboe CC, Billingham M, Eisen H et al (2005) Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT grade 2 and 3A rejection in cardiac allograft recipients. J Heart Lung Transplant 24(7 Suppl):S219–S226. https://doi.org/10.1016/j.healun.2005.04.001
3. Crespo-Leiro MG, Stypmann J, Schulz U et al (2016) Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II. Eur Heart J 37(33):2591–2601. https://doi.org/10.1093/eurheartj/ehv682
4. Di Francesco A, Fedrigo M, Santovito D et al (2018) MicroRNA signatures in cardiac biopsies and detection of allograft rejection. J Heart Lung Transplant 37(11):1329–1340. https://doi.org/10.1016/j.healun.2018.06.010
5. Kittleson MM, Skojec DV, Wittstein IS et al (2009) The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients. J Heart Lung Transplant 28(7):704–709. https://doi.org/10.1016/j.healun.2009.04.019